Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies

Bone Marrow Transplant. 2023 Nov;58(11):1264-1266. doi: 10.1038/s41409-023-02043-y. Epub 2023 Aug 14.

Sharmila Raghunandan^{1

2}, Muna Qayed^{3

4}, Ben K Watkins^{3

4}, Michael Graiser^{4

5}, Lev Gorfinkel^{6

7}, Adrianna Westbrook⁴, Scott Gillespie⁴, Brandi Bratrude⁷, Aleksandra Petrovic⁸, Yvonne Suessmuth^{3

4}, John Horan^{6

7}, Leslie S Kean^{6

7}, Amelia A Langston^{4

5}

¹ Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA. sraghu2@emory.edu.
² Emory University, Atlanta, GA, USA. sraghu2@emory.edu.
³ Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.
⁴ Emory University, Atlanta, GA, USA.
⁵ Winship Cancer Institute, Emory University, Atlanta, GA, USA.
⁶ Dana-Farber Cancer Institute, Boston, MA, USA.
⁷ Boston Children's Hospital, Boston, MA, USA.
⁸ Seattle Children's Hospital, Seattle, WA, USA.

No abstract available

Publication types